Open AccessClinical status of patients with coronary artery disease post COVID-19
Author(s) -
Mukhlisa Rakhmatillaevna Khidoyatova,
U.K. Kayumov,
Feruza Khidoyatovna Inoyatova,
Khurshid Gayratovich Fozilov,
Gulnoz Khamidullaeva,
Aziz Sagdullaevich Eshpulatov
Publication year - 2022
Publication title -
international journal of health and medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2632-9433
DOI - 10.21744/ijhms.v5n1.1858
Subject(s) - medicine , coronary artery disease , disease , cardiology , covid-19 , adverse effect , artery , infectious disease (medical specialty)
The main goal of our study was to identify the activity of cardiac dysfunction based on the analysis of the main cardiological methods of research, such as ECG, echocardiography, 24-hour ECG monitoring in conjunction with laboratory parameters in patients with coronary artery disease (CAD) who underwent mild and moderate COVID-19, without signs of residual effects of lung tissue damage (fibrotization). 52 patients with coronary artery disease were examined, which were divided into 2 groups depending on the past infection in history: 1 group without COVID-19 in history (n=26) (based on history and results of SARS-CoV-2 antibody titer), 2 a group with a history of COVID-19 (n=26), confirmed by relevant documents (tests), but without oxygen therapy and steroids, in order to avoid the influence of a serious illness and drug exposure. Conclusions: dynamic monitoring of hemostasis parameters after the hospital stage in patients with CAD should be carried out in order to prevent adverse cardiovascular outcomes, even with a history of moderate and mild coronavirus infection. One of the aspects of therapeutic rehabilitation in the post-COVID period in patients with IHD is the use of vitamin D preparations.